Harald Hugenschmidt
- Oncology top 10%
- Molecular Biology
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Immunology
- Co-authors
- Clemens UngerDieter MarméJoachim DrevsChristine WittigIlse HofmannH. MadjarGeorg Martiny‐BaronJ M Wood
- Topics
- Pancreatic and Hepatic Oncology Research (7 papers)Cancer Cells and Metastasis (5 papers)Cancer Genomics and Diagnostics (4 papers)
- Cited by
- Cancer ResearchOncologyHepatology
- Partner nations
- NorwayGermanyUnited States
In The Last Decade
Harald Hugenschmidt
13 papers receiving 811 citations
Peers
Comparison fields: 5 of 70
- Oncology 417
- Molecular Biology 384
- Cancer Research 267
- Pulmonary and Respiratory Medicine 189
- Immunology 107
Countries citing papers authored by Harald Hugenschmidt
This map shows the geographic impact of Harald Hugenschmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harald Hugenschmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harald Hugenschmidt more than expected).
Fields of papers citing papers by Harald Hugenschmidt
This network shows the impact of papers produced by Harald Hugenschmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harald Hugenschmidt. The network helps show where Harald Hugenschmidt may publish in the future.
Co-authorship network of co-authors of Harald Hugenschmidt
This figure shows the co-authorship network connecting the top 25 collaborators of Harald Hugenschmidt. A scholar is included among the top collaborators of Harald Hugenschmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harald Hugenschmidt. Harald Hugenschmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 30 | |
| 2 | 4 | |
| 3 | 43 | |
| 4 | 18 | |
| 5 | 24 | |
| 6 | 9 | |
| 7 | 55 | |
| 8 | 46 | |
| 9 | 39 | |
| 10 | 47 | |
| 11 | PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging. | 181 |
| 12 | Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model. | 257 |
| 13 | 73 |
About Harald Hugenschmidt
Harald Hugenschmidt is a scholar working on Cancer Research, Oncology and Urology, having authored 13 papers that have together received 826 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Cells and Metastasis (5 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Cancer Research (267 citations), Oncology (417 citations) and Hepatology (61 citations). Harald Hugenschmidt has collaborated with scholars based in Norway, Germany and United States. Frequent co-authors include Clemens Unger, Dieter Marmé, Joachim Drevs, Christine Wittig, Ilse Hofmann, H. Madjar, Georg Martiny‐Baron, J M Wood, Knut Jørgen Labori and Gro Wiedswang. Their work appears in journals such as The Journal of Immunology, Annals of Surgery and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.